FUTU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Futu Holdings is not a clear buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock has some supportive signals from hedge fund buying, a neutral-to-bullish options skew, and mostly still-positive analyst ratings, but the near-term picture is dominated by regulatory and legal overhangs plus mixed technicals. Given the user wants an immediate, direct call and is unwilling to wait for a perfect entry, the best answer is hold rather than buy today.
FUTU is trading at 95.10, slightly above the previous close of 95.04, but the broader session action showed weakness with a 4.88% regular-market drop. Technically, MACD histogram is positive at 1.646 but contracting, which suggests bullish momentum is weakening. RSI_6 at 42.93 is neutral and does not indicate an oversold rebound setup. Moving averages are converging, showing a lack of strong trend direction. Price is below the pivot level of 98.23 and sitting just above first support at 94.07, with deeper support at 91.5. That places the stock near support, but not in a strong momentum buy zone. The modeled stock trend also points to a mixed setup: slight downside next day and next week, with better upside over the next month.
["Hedge funds are aggressively buying, with buying amount up 1234.10% over the last quarter.", "Goldman Sachs previously added FUTU to its APAC Conviction List and maintained a Buy rating with a high target, citing Hong Kong IPO market improvement and capital market tailwinds.", "Jefferies and BofA still keep Buy ratings despite cutting targets, showing that the long-term business is still viewed positively by some major firms.", "Recent options volume is relatively active compared with 30-day averages, suggesting continued trader interest."]
["Multiple class action lawsuits were filed on 2026-07-02 over alleged CSRC non-compliance and misleading statements.", "The SEC is investigating insider trading claims tied to $100 million in profits before regulatory actions against cross-border brokerages.", "Goldman Sachs downgraded FUTU to Neutral and sharply cut its target due to elevated regulatory uncertainty, fines, and remediation risk.", "BofA and Jefferies also reduced price targets, signaling a softer near-term analyst outlook.", "The stock fell 4.88% in regular trading, showing weak recent price action."]
No usable latest-quarter financial snapshot was provided because the financial snapshot data returned an error. Based on the available analyst commentary, the latest quarter appears to have triggered mixed reactions: Jefferies referenced post-earnings strength and buyback confidence, while Goldman cited higher regulatory costs, fines, remediation of non-compliant mainland client accounts, increased client acquisition costs in new markets, and declining new client AUM. Since the latest quarter season was not explicitly stated in the dataset, it cannot be reliably summarized here.
Recent analyst action is mixed but still tilted cautiously constructive. BofA lowered its target to 180 from 223.50 and kept Buy. Jefferies lowered its target to 170.50 from 224 and kept Buy. JPMorgan raised its target to 100 from 87 but kept Neutral. Goldman Sachs downgraded to Neutral from Buy and cut its target sharply to 102.13 from 210.47 on regulatory concerns, though it had earlier added the stock to its APAC Conviction List with a 205 target. Overall, Wall Street pros see upside potential in the business model and capital market tailwinds, but the cons view is dominated by regulation, legal issues, and estimate cuts.
